| # | Drug | Count |
|---|---|---|
| 0 | OMALIZUMAB | 603 |
| 1 | DUPILUMAB | 369 |
| 2 | PREDNISONE | 30 |
| 3 | CETIRIZINE HYDROCHLORIDE | 28 |
| 4 | FAMOTIDINE | 27 |
| 5 | MONTELUKAST SODIUM | 23 |
| 6 | MONTELUKAST | 22 |
| 7 | EPINEPHRINE | 19 |
| 8 | DIPHENHYDRAMINE HYDROCHLORIDE | 18 |
| 9 | ALBUTEROL SULFATE | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OMALIZUMAB | 603 | 0.0069 |
| 1 | BETAINE | 2 | 0.0019 |
| 2 | IODIXANOL | 4 | 0.0011 |
| 3 | STERILE WATER FOR INJECTION | 4 | 0.0007 |
| 4 | DUPILUMAB | 369 | 0.0007 |
| 5 | POVIDONE-IODINE | 3 | 0.0007 |
| 6 | LEVALBUTEROL HYDROCHLORIDE | 2 | 0.0005 |
| 7 | HYDROXOCOBALAMIN | 2 | 0.0005 |
| 8 | DESONIDE | 2 | 0.0004 |
| 9 | LEVOCETIRIZINE DIHYDROCHLORIDE | 9 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-IgE [EPC] | 603 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 369 |
| 2 | Corticosteroid [EPC] | 44 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 4 | Histamine-2 Receptor Antagonist [EPC] | 27 |
| 5 | Catecholamine [EPC] | 19 |
| 6 | alpha-Adrenergic Agonist [EPC] | 19 |
| 7 | beta-Adrenergic Agonist [EPC] | 19 |
| 8 | Proton Pump Inhibitor [EPC] | 17 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-IgE [EPC] | 603 | 0.0069 |
| 1 | Methylating Agent [EPC] | 2 | 0.0019 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 369 | 0.0007 |
| 3 | Antiseptic [EPC] | 3 | 0.0007 |
| 4 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 5 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 6 | Leukotriene Receptor Antagonist [EPC] | 10 | 0.0003 |
| 7 | Oxytocic [EPC] | 1 | 0.0003 |
| 8 | Ectoparasiticide [EPC] | 1 | 0.0003 |
| 9 | Catecholamine [EPC] | 19 | 0.0002 |